BriaCell Reports Preclinical Bria-OTS+ Tumor-Cell Killing Across Three Cancer Types
BriaCell reported tumor-cell killing in preclinical studies of Bria-OTS+ across three cancer types.
BriaCell reported tumor-cell killing in preclinical studies of Bria-OTS+ across three cancer types.